baber/WOPTO huggingface dataset:
Patent AU-562246-B2 (AU)
Title: Hetero substituted phenyl formamidines
Inventor: BIETTI GIUSEPPE
IPC: C07D271/06
Filed: 1983-03-23
Granted: 1987-06-04
Abstract: The object of the present invention are new pharmacologically active substituted guanidino heterocyclicphenylamidines of the following formula 
<CHEM>
 in which R, R1 and R2 which may be the same or different, each represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, R3 represents a linear or branched alkyl group containing optionally heteroatoms such as oxygen, sulfur or nitrogen atom, a linear or branched alkenyl group, an alkynyl group, a cyano group, a cycloalkyl or cycloaliphatic alkyl group, a bicyclic group, an aryl group, a heterocyclic group or R3 and R2 together with the adiacent nitrogen atom represent a heterocyclic group, R4 represents a hydrogen atom, an alkyl or alkoxy group having 1 to 4 carbon atoms or a halogen atom, Het represents a substituted or unsubstituted heterocyclic group containing two or three heteroatoms and tautomers thereof and acid addition salts of the aforesaid compound. Processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also object of this invention. The new compounds are H2- receptor blocking agents which inhibit gastric acid secretion, and are useful antiulcer agents.
Patent AU-685212-B2 (AU)
Title: Gem-disubstituted azacyclic tachykinin antagonists
Inventor: BAKER RAYMOND
IPC: A61P25/26
Filed: 1995-01-12
Granted: 1998-01-15
Abstract: PCT No. PCT/GB95/00057 Sec. 371 Date Jul. 11, 1996 Sec. 102(e) Date Jul. 11, 1996 PCT Filed Jan. 12, 1995 PCT Pub. No. WO95/19344 PCT Pub. Date Jul. 20, 1995The present invention is directed to certain compounds represented by structural formula I:  t thereof wherein R1, R2, R3, R4, R5, R6, R7, A1, A2, X, m and n are defined herein. The compounds of this invention are tachykinin receptor antagonists and are of particular use in the treatment of pain, inflammation, migraine and emesis.
Patent AU-597816-B2 (AU)
Title: Method for optical communication of information
Inventor: ROCKS MANFRED
IPC: H04B10/64
Filed: 1988-04-20
Granted: 1990-06-07
Abstract: The invention describes a method for optical communication of information between transmitter and receiver spatially separated from each other. The principle of heterodyne reception is utilized. A non-modulated optical carrier of a laser arranged on the receiving side is subdivided in a first fiber-optical coupler KE into two portions, the transmission path EMF and the local laser wave LL. In one branch, a displacement of frequency by the amount of  DELTA f takes place. The non-modulated optical carrier passes through a one-mode fiber EMF in direction transmitting side and is modulated there with an effective signal in a modulator MOD (FIG. 1). This now modulated optical signal travels back to the receiving side, where it is converted with the local laser wave LL into an intermediate frequency band.
Patent AU-594574-B2 (AU)
Title: A process for the production of alloy powders for dental amalgams
Inventor: GROLL WERNER DR
IPC: A61K6/847
Filed: 1988-05-23
Granted: 1990-03-08
Abstract: An economical alloyed powder for dental amalgams exhibiting good working properties is obtained from pressed and sintered molded bodies by mechanical comminution. The formed body is produced by mixing and pressing powders of elemental silver, copper and tin with a subsequent sintering between 150 DEG  C. and the solidus temperature of the alloy being formed. The sintering is performed until a homogeneous distribution of the tin has been achieved in the silver and copper particles.
Patent AU-736335-B2 (AU)
Title: Amino- and hydroxysubstituted triphenyl-S-triazines as stabilizers
Inventor: REINEHR DIETER
IPC: C08K5/3492
Filed: 1997-03-17
Granted: 2001-07-26
Abstract: The present invention provides compounds having the formula (1) or (1A) in which R is hydrogen, hydroxy, halogen, C1-C20-alkyl, C4-C12cycloalkyl, C2-C20alkenyl, C2-C20alkynyl, C1-C20-alkoxy, C4-C12cycloalkoxy, C2-C20alkenoxy, C2-C20alkynoxy or C7-C13aralkyl; R1 and R2, independently, are hydrogen, C1-C20alkyl, C4-C12cycloalkyl, C7-C13aralkyl, -C(=O)-R4 (in which R4 is C1-C20alkyl, C2-C20alkyl interrupted by 1 to 6 oxygen atoms, hetero-substituted C1-C20alkyl, C4-C12cycloalkyl, C2-C20alkenyl, C2-C20alkynyl, C1-C20alkoxy, C4-C12cycloalkoxy, C2-C20alkenoxy, C2-C20alkynoxy, C6-C12aryl, C6-C12aryloxy or C7-C13aralkyl), or -C(=O)-NH-R1 in which R1 has its previous significance; and R3 is hydrogen, halogen, hydroxy, C1-C20alkyl, C4-C12cycloalkyl, C2-C20alkenyl, C2-C20alkynyl, C1-C20-alkoxy, C4-C12cycloalkoxy, C2-C20alkenoxy, C2-C20alkynoxy, phenyl, C7-C13aralkyl or -N(R1)(R2) in which R1 and R2 have their previous significance, or R1 and R2 together form a C4-C12 membered ring. The new triphenyltriazine compounds have improved absorption spectrum characteristics and superior resistance to exposure to UV light, relative to known triphenyltriazine compounds.
Patent AU-655648-B2 (AU)
Title: Substituted benzoyl isoxazoles and herbicidal compositions
Inventor: CAIN PAUL ALFRED
IPC: A01N43/80
Filed: 1992-08-03
Granted: 1995-01-05
Abstract: 4-Benzoyl isoxazole derivatives of general formula (I): <CHEM>  wherein:     R<1> represents cyclopropyl;     R<2> represents -S(O)nR;     R<3> represents chlorine, bromine or trifluoromethyl;     R represents methyl; and     n represents 2; and their use as herbicides is described. >  w
Patent AU-594585-B2 (AU)
Title: User circuit priority means
Inventor: SIMAEYS FRANCOISE CATHERINE GA
IPC: H04Q11/04
Filed: 1988-09-14
Granted: 1990-03-08
Abstract: Telecommunication switching system and priority arrangement used therein. The switching system includes a plurality of control circuits (DPTC/31) which are each common to a plurality of line circuits (SLIC, DSP, TCF, DPTC) and which are connected via respecitve time division multiplex links (TINA/B, TOUTA/B) with two inferface circuits (TCEA/B) themselves coupled with a switching network (SNW). The transmission of line scanning data between the control circuits and the interface circuits occurs in channel (16) of the time division multiplex links. The priority of transmission is determined by the priority device (CLHA/B).
Patent AU-670036-B2 (AU)
Title: Carton for several articles and blank therefor
Inventor: CAMPBELL GEOFFREY
IPC: B65D71/32
Filed: 1992-08-07
Granted: 1996-07-04
Abstract: PCT No. PCT/GB92/01472 Sec. 371 Date May 5, 1994 Sec. 102(e) Date May 5, 1994 PCT Filed Aug. 7, 1992 PCT Pub. No. WO93/02944 PCT Pub. Date Feb. 18, 1993.There is provided a carton 11 for holding a number of articles 34. There is a bottom panel 12, two side walls 13, 14, end panels 17 and overlapping top panels 26, 28. The overlapping portions of panels 26, 28 are glued together and there is a cut-out portion 30 in the outer top panel 26. The cut-out portion 30 lies adjacent the overlapping portions and midway between the carton ends.
Patent AU-784463-B2 (AU)
Title: Wireless clock synchronization
Inventor: BEKRITSKY BENJAMIN J
IPC: H04M1/72415
Filed: 2001-11-14
Granted: 2006-04-06
Abstract: The location of unmodified wireless assets in a wireless communication network may be identified using time differences of arrivals of a communication sequence at different network receivers. Time-stamping devices may include correlator circuits in parallel with signal decoders to time-stamp communication sequences. Cellular wireless networks may be frequency-multiplexed to increase spatial time-stamping density. Tags may be attached to passive assets to provide location identification information to network devices. Locations of assets broadcasting standard 802.11 radio frequency structures may be identified. Noise inherent in correlating a communication sequence may be reduced by using a selected correlation function.
Patent AU-565935-B2 (AU)
Title: Production of sponge iron in vertrical shaft furnace
Inventor: MARTINEZ-VERA ENRIQUE RAMON
IPC: C21B13/02
Filed: 1984-05-15
Granted: 1987-10-01
Abstract: A method for the gaseous reduction of iron ore to sponge iron in a vertical shaft moving bed reactor (10) wherein a hot gaseous mixture of hydrogen and a carbon monoxide is used to reduce the ore. It has been found unnecessary to use the external catalytic reformer of prior art processes to reform the methane and other hydrocarbon constituents of the natural gas commonly used as a source of gaseous reductants. By establishing a reducing gas recycle loop to which make-up natural gas and steam are fed in the proper proportions, the product sponge iron in the reactor (10) can be used to catalyze hydrocarbon reformation, provided that the carbon content of the recycled gas is maintained low by removing carbon dioxide therefrom. When pure methane is employed, steam/methane molar ratios within the preferred range of 1,4 : 1 to 2.2 : 1 are used.
Patent AU-560909-B2 (AU)
Title: No rinse metal treatment
Inventor: SANDER LOTHAR S
IPC: C23C22/33
Filed: 1984-07-02
Granted: 1987-04-16
Abstract: An acidic aqueous no-rinse solution for coating metallic surfaces to make them corrosion resistant containing hexavalent chromium, trivalent chromium, phosphoric acid, and a poly(alkyleneoxy) polymer. Said solution is stable at both high and low temperatures.
Patent AU-730564-B2 (AU)
Title: Cosmetic cream composition containing silicone gel material
Inventor: LEE WILSON
IPC: A61K8/14
Filed: 1997-05-21
Granted: 2001-03-08
Abstract: Disclosed is a solid cosmetic composition (e.g., a cream composition) containing an active cosmetic material (e.g., a deodorant active, an antiperspirant active, a sunscreen, an insect repellent and/or an anti-fungal agent) and a silicone gel material. The silicone gel material includes (a) a volatile silicone material and (b) an organopolysiloxane material as a gelling agent, able to form a gel after being mixed with the volatile silicone material. The organopolysiloxane material can be a reaction product of a vinyl-terminated siloxane polymer and a hydride cross-linking agent. The composition can be formed by mixing the active cosmetic material and silicone gel material at ambient temperature. The compositions do not need particulate or clay thickeners or waxy gelling agents.
Patent AU-663544-B2 (AU)
Title: Improvements in or relating to belt filters
Inventor: COTTAM ALAN
IPC: B01D24/46
Filed: 1992-12-03
Granted: 1995-10-12
Abstract: PCT No. PCT/GB92/02249 Sec. 371 Date Aug. 23, 1994 Sec. 102(e) Date Aug. 23, 1994 PCT Filed Dec. 3, 1992 PCT Pub. No. WO93/11850 PCT Pub. Date Jul. 24, 1993.A liquid filtration apparatus for improved water handling capacity of a belt filter comprising a continuously movable filtering medium, an advancing length of which being immersible in a container of contaminated liquid, a driving device to move the filter medium through the contaminated liquid, a device for cleaning contaminates from the filtering medium and a device for removing cleansed liquid from the filter from above the filtering medium in the region of immersion in the contaminated liquid.
Patent AU-777732-B2 (AU)
Title: Molasses-containing crystal composition and method for producing the same
Inventor: UENO RYUZO
IPC: A23L27/30
Filed: 2001-02-14
Granted: 2004-10-28
Abstract: A crystalline mixture solid composition which has almost no hygroscopicity, is easy to handle and dissolve and hardly worn by abrasion, and comprises  alpha -D-glucopyranosyl-1,1-mannitol and alpha -D-glucopyranosyl-1,6-sorbitol and may further comprise  alpha -D-glucopyranosyl-1,1-sorbitol in a certain case is obtained in an extremely short period of time by a power-saving and labor-saving process with a small-scale apparatus. A composition which comprises 20 to 75 wt% of  alpha -D-glucopyranosyl-1,1-mannitol, 23 to 70 wt% of  alpha -D-glucopyranosyl-1,6-sorbitol and 2 to 25 wt% of  alpha -D-glucopyranosyl-1,1-sorbitol and is in a crystalline mixture solid state or has a specific surface area of 0.07 to 0.1 m<2>/g, and a composition which comprises 30 to 75 wt% of  alpha -D-glucopyranosyl-1,1-mannitol, 25 to 70 wt% of  alpha -D-glucopyranosyl-1,6-sorbitol and has a specific surface area of 0.07 to 0.1 m<2>/g. The above compositions are produced by a process comprising supplying a raw material, which is obtained by optionally removing trehalulose from a mixture containing isomaltulose and trehalulose produced from cane sugar through an isomerization reaction and hydrogenating into a kneader having a thin and long cooling zone together with seed crystals and discharging the obtained composition from an outlet continuously.
Patent AU-761684-B2 (AU)
Title: Minicapsulorhexis valve
Inventor: TAHI HASSAN
IPC: A61F9/007
Filed: 2000-02-22
Granted: 2003-06-05
Abstract: A mini capsulorhexis valve device is composed of a curved, flexible discoid flap-valve member shaped to align with an ocular lens capsular bag inner surface, and a curved, flexible retainer member shaped to align with an ocular lens capsular bag outer surface, the curved, flexible retainer member being attached at a fastening point to the curved, flexible discoid flap-valve member. Attachment of the curved, flexible discoid flap-valve member to the curved, flexible retainer member may be via bonding with a silastic adhesive. In a method of accessing an ocular lens, the mini capsulorhexis valve device establishes a portal controlling access to an ocular lens. The method may include inserting a cannula through the mini capsulorhexis valve device to permit removal of a crystalline lens matrix and replacement thereof with a capsular filling material. The method may also include injecting a cytotoxic agent into a lens capsule, during which leakage of the injected cytotoxic agent is prevented by the mini capsulorhexis valve device. The method may further include adjusting the refractive power of capsular filling material by adding or removing capsular filling material from the lens capsule during lens replacement surgery or post-surgically.
Patent AU-618365-B2 (AU)
Title: Corrosion control
Inventor: KREH ROBERT PAUL
IPC: C09K15/26
Filed: 1989-06-07
Granted: 1991-12-19
Abstract: A method of removing iron contaminants in an aqueous system by introducing and maintaining within the system an ortho dihydroxylaromatic compound having at least one electron withdrawing group pendant from the aromatic ring and, further, a method of inhibiting calcium scale formation in the presence of iron contaminants by utilizing a dihydroxylaromatic compound in combination with a calcium scale inhibitor.
Patent AU-732125-B2 (AU)
Title: Infectious papillomavirus pseudoviral particles
Inventor: LOWY DOUGLAS R
IPC: A61K35/76
Filed: 1997-07-14
Granted: 2001-04-12
Abstract: The invention provides an infectious papillomavirus pseudoviral particle useful in gene transfer comprising: (a) a papillomavirus vector DNA which comprises an E2 binding site and an expression cassette comprising a gene and a sequence controlling expression of said gene; and (b) a papillomavirus capsid which comprises L1 and L2 structural proteins, such that said capsid encapsidates said vector DNA, wherein said gene is derived from a first biological species and said L1 structural protein is derived from a second biological species and said first biological species is different from said second biological species.
Patent AU-566977-B2 (AU)
Title: Tamper-resistant closure
Inventor: DAVIS EUGENE EDWARD
IPC: B65D41/48
Filed: 1985-01-02
Granted: 1987-11-05
Abstract: The invention provides a container closure with a top, a skirt depending from the top, a tear-away tamper resistant band connected to the skirt by frangible means and a tear tab on the band arranged so that it is inclined upwardly and outwardly in order to ensure that when a container with a closure in position is being packed into a carton bottom end first the tear tab on the closure does not catch on the rim of the carton. Preferably the teartab is connected by a frangible tongue to a thumb push on the skirt and disposed immediately above the tear tab.
Patent AU-618394-B2 (AU)
Title: Factor regulating gene expression
Inventor: TANIGUCHI TADATSUGU
IPC: C07K14/565
Filed: 1989-08-23
Granted: 1991-12-19
Abstract: A recombinant DNA molecule coding for a protein having the activity of an interferon regulatory factor-1 (IRF-1).
Patent AU-654778-B2 (AU)
Title: Process and reagent for the specific determination of LDL in serum samples
Inventor: BOOS KARL-SIEGFRIED
IPC: G01N33/68
Filed: 1993-07-12
Granted: 1994-11-17
Abstract: The invention relates to a process and reagent for the specific determination of the LDL fraction in the presence of other lipoproteins in the serum by adding a polymeric LDL-aggregating polyanion and measuring the LDL aggregate by direct turbidimetry. Preferred polyanions have a comb-like structure where the side branches comprise acidic groups, especially branched alkanesulphonic acids.
Patent AU-596947-B2 (AU)
Title: Prostaglandin analogues, processes for their preparation and pharmaceutical compositions containing them
Inventor: IMAKI KATSUHIRO
IPC: C07C405/00
Filed: 1985-07-22
Granted: 1990-05-24
Abstract: The present invention relates to novel isomers of PGAs, PGDs, PGEs, PGFs, 6-keto-PGE<sub>1</sub>s, 6-keto-PGF<sub>1</sub>s, PGl<sub>2</sub>s, 6,9a-nitrilo-PGl<sub>1</sub>s and 6,α-methano-PGl<sub>2</sub>s, having a specific steric configuration, which are replaced by an alkyl (C<sub>1</sub> to C<sub>8</sub>)-substituted cycloalkyl (C<sub>4 </sub>to C<sub>7</sub>) group in (1S, S) form, in (1S, R) form or in cis form at the 15-, 16- or 17-position of the PG skeleton, and, alkyl esters thereof, non-toxic salts thereof, non-toxic acid addition salts thereof and cyclodextrin clathrates thereof, possessing more potent PG-like pharmacological activity than other isomers.
Patent AU-621968-B2 (AU)
Title: Process for separating organometallic compounds and/or metal carbonyls from their solutions in organic media
Inventor: BAHRMANN HELMUT DR
IPC: B01J37/00
Filed: 1989-12-19
Granted: 1992-03-26
Abstract: The separation of organometallic compounds and/or metal carbonyls from their solutions in organic media is effected according to the invention with the aid of semipermeable membranes of an aromatic polyamide.
Patent AU-578733-B2 (AU)
Title: Process for insertion of motor-vehicle window
Inventor: ARMBRUSTER GUNTER
IPC: B60R13/06
Filed: 1985-09-13
Granted: 1988-11-03
Abstract: A rigid window pane having an edge is mounted in a rigid window opening having a rigid border with an annular gasket by first providing on the outer periphery of the gasket a layer of adhesive and fitting the gasket around the edge of the pane. Then the pane carrying the gasket is fitted to the window opening with the adhesive layer engaging the opening border and at the same time the pane carrying the gasket is heated and pressed into this opening to soften the gasket until it externally deforms plastically to complementarily fit the opening border. Subsequently the gasket is cooled and cured so it hardens and retains the shape imparted to it by the heat and pressure. The gasket is formed of a thermoplastic synthetic resin or of a vulcanizable or polymerizable, that is heat-curing, synthetic resin or rubber. The polymerization can include the processes of polycondensation or polyaddition.
Patent AU-766282-B2 (AU)
Title: Pharmaceutical compositions comprising 2-quinolones
Inventor: JOSEPH BENOIT
IPC: C07D401/12
Filed: 1999-07-13
Granted: 2003-10-16
Abstract: The invention concerns a pharmaceutical composition having an activity on the proliferation of clonogenic cells in tumours and comprising an efficient amount of a compound selected among the compounds of formulae (I) and (Ia) wherein: X, R1, R2, R3, R4, R5, R6 are as defined in claim 1.
Patent AU-586647-B2 (AU)
Title: Improvements in or relating to peptides that inhibit renin
Inventor: HOELZEMANN GUENTER
IPC: C07K5/00
Filed: 1985-10-21
Granted: 1989-07-20
Abstract: New peptides of the formula I X-Z-NH-CHR-CHOH-CH2-CO-NH-CHR1-CH2-NH-CHY-CnH2n-R2 I in which X is H, R3-O-CH2-CO-, R3-O-CO-, R3-CH2-O-CO- or R3-CmH2m-CO-, Z is 1 to 4 aminoacid residues which are bonded together in the manner of peptides and are selected from the group comprising Abu, Ala, Arg, Asn, Dab, Gln, Gly, His, Ile, Leu, Lys, Met, NLeu, Orn, Phe, Pro, Trp, Tyr and Val, is A, Ar-alkyl (in which the group -alkyl contains 1-4 C atoms) or cycloalkyl-alkyl having 4-11 C atoms, R1 is H or A, Y is H, A, -CpH2p-OR4, -CpH2p-NHR4, -COOR4, -CONHR4 or -CONA2, R2 is A, cycloalkyl having 3-7 C atoms, Ar, pyridyl, indolyl, imidazolyl, piperidyl, N-benzylpiperidyl or piperazinyl, R3 is A, cycloalkyl having 3-7 C atoms or Ar, R4 is H, A or cycloalkyl having 3-7 C atoms, A is alkyl having 1-6 C atoms, Ar is phenyl which is unsubstituted or substituted once or several times by A, AO, F, Cl, Br, I, CF3 and/or NH2, or is unsubstituted naphthyl, and m, n and p each are 0, 1, 2, 3, 4 or 5, and their salts inhibit the activity of the renin in human plasma.
Patent AU-780223-B2 (AU)
Title: Voice filter for normalizing an agent's emotional response
Inventor: SHAMBAUGH CRAIG R
IPC: G10L13/02
Filed: 2001-07-12
Granted: 2005-03-10
Abstract: A method and apparatus are provided for adjusting a content of an oral presentation provided by an agent of an organization and perceived by a human target of the organization based upon an objective of the organization. The method includes the steps of detecting a content of the oral presentation provided by the agent and modifying the oral presentation provided by the agent to produce the oral presentation perceived by the human target based upon the detected content and the organizational objective. <IMAGE>
Patent AU-753251-B2 (AU)
Title: Oral liquid mucoadhesive compositions
Inventor: DOBROZSI DOUGLAS JOSEPH
IPC: A61P23/00
Filed: 1999-08-24
Granted: 2002-10-10
Abstract: The present invention relates to a per oral, oral, or intranasal pharmaceutical mucoretentive, aqueous liquid composition comprising from about 2% to about 50%, by weight of the composition, of colloidal particles of silica, titanium dioxide, clay, and mixtures thereof and a safe and effective amount of a pharmaceutical active selected from the group consisting of analgesics, decongestants, expectorants, antitussives, antihistamines, sensory agents, gastrointestinal agents, and mixtures thereof; wherein the composition has a sedimentation volume ratio of greater than about 0.90 and wherein the triggered viscosity ratio of the composition is at least about 1.2. The present invention further relates to a method of coating the alimentary canal and nasal mucosa, in particular to a method of preventing or treating symptoms of upper respiratory tract infections or upper respiratory tract tissue irritation or damage, by administering a safe and effective amount of the above composition.
Patent AU-645253-B2 (AU)
Title: Leukotriene antagonists
Inventor: FRAZEE JAMES SIMPSON
IPC: C07D257/04
Filed: 1990-06-08
Granted: 1994-01-13
Abstract: Compounds represented by the following structural formula (I): <CHEM>  wherein q is O or 2;  R1 is (L)a-(CH2)b-(T)c-M  a is 0 or 1;  b is 3 to 14;  c is 0 or 1;  L and T are independently oxygen or CH2; M is C1-4 alkyl, ethynyl, trifluoromethyl, isopropenyl, furanyl, thienyl, cyclohexyl or phenyl optionally monosubstituted with Br, Cl, CF3, alkoxy, alkyl, methylthio, or trifluoromethylthio;    Y is (CHX)(CH2)p-Z wherein  Z is COR3, or tetrazolyl; in which  R3 is OH, NH2, aryloxy, or C1-6 alkoxy;  p is 0, 1 or 2;  X is OH, or alkoxy;  R is -(CH2)p-W;  d is 0 to 6;  W is phenyl substituted with B, C, or D; B is-(CH2)p-V wherein p is 0 to 6 and V is COR3, SO3H, SO2H, SO2NH2, COCH2OH, CHOHCH2OH, or tetrazolyl, with R3 as defined above; C and D are independently selected from H, OH, F, Cl, Br, CF3, alkyl, alkoxy, methylthio, trifluoromethylthio, NO2, NH2, NHalkyl, or CalkylCO-; or pharmaceutically acceptable salts thereof, can be used in the preparation of a medicament for the treatment of asthma.